Officer and Director Mark Hancock files intent to sell $6.44 million in PACS Group stock
PACS has more than doubled off its 52-week low of $7.5.
Summary
Officer and Director Mark Hancock intends to sell $6.44 million in PACS Group stock, continuing a trend of significant insider sales while the stock is near its 52-week high.
Key Events · Ownership and Investor Activity · PACS
-
Intent to Sell Significant Shares
Officer and Director Mark Hancock filed a Form 144 to sell 142,163 shares of common stock, valued at approximately $6.44 million.
-
Ongoing Insider Distribution
This proposed sale follows previous sales by Hancock totaling nearly $20 million over the past three months, indicating a sustained pattern of insider selling.
-
Stock Trading Near 52-Week High
The intent to sell comes as PACS Group's stock is trading near its 52-week high of $45.89, potentially signaling profit-taking by the insider.
Analysis · PACS · Industrial Applications And Services
Mark Hancock, an Officer and Director, has filed a Form 144 indicating his intent to sell $6.44 million worth of PACS Group common stock. This proposed sale adds to a pattern of significant insider selling by Hancock, who has already sold nearly $20 million in shares over the past three months. The filing occurs while the stock is trading near its 52-week high, suggesting the insider is taking profits. This ongoing distribution by a key executive could be viewed negatively by investors.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 28.9% of the 1666 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PACS was trading at $45.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $7.50 to $45.89. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.